Exploiting solid lipid nanoparticles and nanostructured lipid carriers for drug delivery against cutaneous fungal infections

References

• Aggarwal N, Goindi S. 2013. Preparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal use. J Biomed Nanotechnol. 9(4):564–576.
   PubMed Web of Science ®Google Scholar
• Almeida AJ, Souto E. 2007. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev. 59(6):478–490.
   PubMed Web of Science ®Google Scholar
• Andrade F, Rafael D, Videira M, Ferreira D, Sosnik A, Sarmento B. 2013. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Adv Drug Deliv Rev. 65(13-14):1816–1827. Elsevier.
   PubMed Web of Science ®Google Scholar
• Araujo VHS, da Silva PB, Szlachetka IO, da Silva SW, Fonseca-Santos B, Chorilli M, et al. 2020. The influence of NLC composition on curcumin loading under a physicochemical perspective and in vitro evaluation. Colloids Surfaces A Physicochem Eng Asp. 602:125070.
   Web of Science ®Google Scholar
• Bhalekar MR, Pokharkar V, Madgulkar A, Patil N, Patil N. 2009. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech. 10(1):289–296.
   PubMed Web of Science ®Google Scholar
• Bhatia S, Bhatia S. 2016. Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications. In: Natural polymer drug delivery systems. Cham: Springer International Publishing; p. 33–93.
   Google Scholar
• Bhushan B. 2017. Introduction to nanotechnology. In: Bhushan B, editor. Springer handbook of nanotechnology. 4th ed. Berlin, Heidelberg: Springer-Verlag; p. 1–19.
   Google Scholar
• Bunjes H. 2011. Current opinion in colloid & interface science structural properties of solid lipid based colloidal drug delivery systems. Curr Opin Colloid Interface Sci. 16(5):405–411.
   Web of Science ®Google Scholar
• Butani D, Yewale C, Misra A. 2016. Topical amphotericin B solid lipid nanoparticles: design and development. Colloids Surf B Biointerfaces. 139:17–24.
   PubMed Web of Science ®Google Scholar
• Buttaravoli P, Leffler SM. 2012. Tinea Pedis, Tinea Cruris, Tinea Corporis. In: Minor Emerg. 3rd ed. Amsterdam: Elsevier. p0733–739.
   Google Scholar
• Carbone C, Teixeira M. d C, Sousa M. d C, Martins-Gomes C, Silva AM, Souto EMB, Musumeci T. 2019. Clotrimazole-loaded mediterranean essential oils NLC: a synergic treatment of Candida skin infections. Pharmaceutics. 11(5):231.
   PubMed Web of Science ®Google Scholar
• Carlos IZ, Batista-Duharte A. 2015. Sporotrichosis: an emergent disease. In: Carlos IZ, editor. Sporotrichosis: new developments and future prospects. Switzerland: Springer; p. 1–179.
   Google Scholar
• Carrasco-Zuber JE, Navarrete-Dechent C, Bonifaz A, Fich F, Vial-Letelier V, Berroeta-Mauriziano D. 2016. Cutaneous involvement in the deep mycoses: a literature review. Part I—subcutaneous mycoses. Actas Dermosifiliogr. 107(10):806–815.
   PubMed Web of Science ®Google Scholar
• De Toledo L, Ramos M, Spósito L, Castilho E, Pavan F, Lopes É, Zocolo G, Silva F, Soares T, dos Santos A, É, et al. 2016. Essential oil of cymbopogon nardus (L.) Rendle: a strategy to combat fungal infections caused by candida species. IJMS. 17(8):1252.
   Google Scholar
• Doktorovova S, Souto EB, Silva AM. 2014. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - A systematic review of in vitro data. Eur J Pharm Biopharm. 87(1):1–18.
   PubMed Web of Science ®Google Scholar
• Dos Santos Ramos MA, Da Silva PB, Spósito L, De Toledo LG, Bonifácio BV, Rodero CF, Dos Santos KC, Chorilli M, Bauab TM. 2018. Nanotechnology-based drug delivery systems for control of microbial biofilms: a review. Int J Nanomedicine. 13(3):1179–1213.
   PubMedGoogle Scholar
• Dwi Ratna Adisty LA. 2017. Tinea capitis favus-like appearance : problem of diagnosis. BIKKK Period Dermatology Venereol. 29:264–265.
   Google Scholar
• El-Housiny S, Eldeen MAS, El-Attar YA, Salem HA, Attia D, Bendas ER, et al. 2018. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: Formulation and clinical study. Drug Deliv. 25(1):78–90.
   PubMed Web of Science ®Google Scholar
• Ely J, Rosenfeld S, Stone M. 2014. Diagnosis and management of tinea capitis. Pediatr Ann. 16(1):39–48.
   Google Scholar
• Emerich DF, Thanos CG. 2003. Nanotechnology and medicine. Expert Opin Biol Ther. 3(4):655–663.
   PubMed Web of Science ®Google Scholar
• Ferry M, Shedlofsky L, Newman A, Mengesha Y, Blumetti B. 2020. Tinea InVersicolor: a rare distribution of a common eruption. Cureus. 12(1):1–6.
   Web of Science ®Google Scholar
• Garcês A, Amaral MH, Sousa Lobo JM, Silva AC. 2018. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review. Eur J Pharm Sci. 112:159–167.
   PubMed Web of Science ®Google Scholar
• Garg A, Singh S. 2014. Targeting of eugenol-loaded solid lipid nanoparticles to the epidermal layer of human skin. Nanomedicine (Lond). 9(8):1223–1238.
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Isham NC. 2009. Dermatophytes and dermatophytoses. In: Nguyen T, Hodgson S, editors. Clinical Mycology. Amsterdam: Elsevier; p. 375–384.
   Google Scholar
• Gordillo-Galeano A, Mora-Huertas CE. 2018. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. Eur J Pharm Biopharm. 133:285–308.
   PubMed Web of Science ®Google Scholar
• Gremião IDF, Miranda LHM, Reis EG, Rodrigues AM, Pereira SA. 2017. Zoonotic epidemic of sporotrichosis: cat to human transmission. PLoS Pathog. 13(1):e1006077.
   PubMed Web of Science ®Google Scholar
• Guarana M, Nucci M. 2018. Acute disseminated candidiasis with skin lesions: a systematic review. Clin Microbiol Infect. 24(3):246–250.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Shear NH, Piguet V, Tosti A, Friedlander SF. 2018. Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol. 32(12):2264–2274. p.
   PubMed Web of Science ®Google Scholar
• Gupta M, Vyas SP. 2012. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids. 165(4):454–461.
   PubMed Web of Science ®Google Scholar
• H. Muller R, Shegokar R M, Keck C. 2011. 20 Years of Lipid Nanoparticles (SLN and NLC): present state of development and industrial applications. Curr Drug Discov Technol. 8(3):207–227.
   PubMedGoogle Scholar
• Haider M, Abdin SM, Kamal L, Orive G. 2020. Nanostructured lipid carriers for delivery of chemotherapeutics : a review. Pharmaceutics. 12(3):288.
   PubMed Web of Science ®Google Scholar
• Harde H, Das M, Jain S. 2011. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv. 8(11):1407–1424.
   PubMed Web of Science ®Google Scholar
• Hay RJ. 2017. Tinea Capitis: current status. Mycopathologia. 182(1-2):87–93.
   PubMed Web of Science ®Google Scholar
• Howell SA, Clayton YM, Phan QG, Noble WC. 1988. Tinea pedis: the relationship between symptoms, organisms and host characteristics. Microb Ecol Health Dis. 1(2):131–135.
   Google Scholar
• Hube B, Hay R, Brasch J, Veraldi S, Schaller M. 2015. Dermatomycoses and inflammation: the adaptive balance between growth, damage, and survival. J Mycol Med. 25(1):e44–e58.
   PubMed Web of Science ®Google Scholar
• Jain S, Jain S, Khare P, Gulbake A, Bansal D, Jain SK. 2010. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Deliv. 17(6):443–451.
   PubMed Web of Science ®Google Scholar
• Jaiswal P, Gidwani B, Vyas A. 2016. Nanostructured lipid carriers and their current application in targeted drug delivery. Artif Cells Nanomed Biotechnol. 44(1):27–40.
   PubMed Web of Science ®Google Scholar
• Khosravi AR, Mansouri P, Saffarian Z, Vahedi G, Nikaein D. 2018. Chronic mucocutaneous candidiasis, a case study and literature review. J Mycol Med. 28(1):206–210.
   PubMed Web of Science ®Google Scholar
• Lasoń E, Ogonowski J. 2011. Solid lipid nanoparticles – characteristics, application and obtaining. Chem Int. 65(10):960–967.
   Google Scholar
• Le Roux G, Moche H, Nieto A, Benoit JP, Nesslany F, Lagarce F. 2017. Cytotoxicity and genotoxicity of lipid nanocapsules. Toxicol in Vitro. 41:189–199.
   PubMed Web of Science ®Google Scholar
• Lehman H, Gordon C. 2019. The skin as a window into primary immune deficiency diseases: atopic dermatitis and chronic mucocutaneous candidiasis. J Allergy Clin Immunol Pract. 7(3):788–798.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang ZW, Luo Y, Liang N, Pi XX, Fan YM. 2020. Molecular epidemiology, in vitro susceptibility and exoenzyme screening of Malassezia clinical isolates. J Med Microbiol. 69(3):436–442.
   PubMed Web of Science ®Google Scholar
• Luiza Ribeiro de Souza A, Priscila Kiill C, Kolenyak dos Santos F, Marielli da Luz G, Rocha e Silva H, Chorilli M, Palmira Daflon Gremiao M. 2012. Nanotechnology-based drug delivery systems for dermatomycosis treatment. CNANO. 8(4):512–519.
   Google Scholar
• Mahajan VK. 2014. Sporotrichosis: an overview and therapeutic options. Dermatol Res Pract. 2014:272376.
   PubMedGoogle Scholar
• Maródi L. 2014. Mucocutaneous candidiasis. In: Sullivan K, Stiehm ER, editors. Stiehm’s immune deficiencies. 1st ed. Amsterdam: Elsevier; p. 775–802.
   Google Scholar
• Mathur M, Acharya P, Karki A, Nisha KC, Shah J. 2019. Dermoscopic pattern of pityriasis versicolor. Clin Cosmet Investig Dermatol. 12:303–309.
   PubMed Web of Science ®Google Scholar
• Maza-Morales M, Rivas-Calderón MK, Barrón-Calvillo EE, García-Romero MT. 2020. Coccidioidomycosis in children and adolescents: an update. Curr Fungal Infect Rep. 14(2):106–168.
   Web of Science ®Google Scholar
• Mishra V, Bansal KK, Verma A, Yadav N, Thakur S. 2018. Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics. 10(4):191.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 54(SUPPL):131–155.
   Google Scholar
• Na Y-G, Huh HW, Kim M-K, Byeon J-J, Han M-G, Lee H-K, Cho C-W. 2020. Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes. Acta Biomater [Internet]. 101:507–518.
   PubMed Web of Science ®Google Scholar
• Neethirajan S, Clond MA, Vogt A. 2014. Medical biofilms-nanotechnology approaches. J Biomed Nanotechnol. 10(10):2806–2827. Vol. 10, American Scientific Publishers.
   PubMed Web of Science ®Google Scholar
• Nikalje AP, Thanos CG. 2015. Nanotechnology and its applications in medicine. Med Chem. 5:2.
   Google Scholar
• Pardeshi C, Rajput P, Belgamwar V, Tekade A, Patil G, Chaudhary K, Sonje A. 2012. Solid lipid based nanocarriers: an overview. Acta Pharm. 62(4):433–472.
   PubMed Web of Science ®Google Scholar
• Passos JS, Martino LD, Dartora VFC, Araujo GD, Ishida K, Lopes LB. 2020. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole. Eur J Pharm Sci [Internet]. 149:105296.
   PubMed Web of Science ®Google Scholar
• Pereira RR, Testi M, Rossi F, Silva Junior JOC, Ribeiro-Costa RM, Bettini R, Santi P, Padula C, Sonvico F. 2019. Ucuùba (Virola surinamensis) Fat-based nanostructured lipid carriers for nail drug delivery of ketoconazole: development and optimization using box-behnken design. Pharmaceutics. 11(6):284.
   PubMed Web of Science ®Google Scholar
• Piraccini B, Alessandrini A. 2015. Onychomycosis: a review. J Fungi (Basel). 1(1):30–43.
   PubMedGoogle Scholar
• Porche DJ. 2006. Tinea cruis: a bothersome male condition. J Nurse Pract. 2(2):84–85.
   Google Scholar
• Porche DJ. 2006. Tinea pedis: a common male foot problem. J Nurse Pract. 2(3):152–153.
   Google Scholar
• Ramasamy T, Khandasami US, Ruttala H, Shanmugam S. 2012. Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent. Macromol. Res. 20(7):682–692.
   Web of Science ®Google Scholar
• Ramos AP, Cruz MAE, Tovani CB, Ciancaglini P. 2017. Biomedical applications of nanotechnology. Biophys Rev. 9(2):79–89.
   PubMedGoogle Scholar
• Richardson MD, Moore CB. 2017. Superficial and subcutaneous fungal pathogens. In: Infectious Diseases 4th ed. Amsterdam: Elsevier Ltd; p. 1710–1724.e1 p.
   Google Scholar
• Rocha KAD, Krawczyk-Santos AP, Andrade LM, Souza L. C d, Marreto RN, Gratieri T, Taveira SF. 2017. Voriconazole-loaded nanostructured lipid carriers (NLC) for drug delivery in deeper regions of the nail plate. Int J Pharm. 531(1):292–298.
   PubMed Web of Science ®Google Scholar
• Sala M, Diab R, Elaissari A, Fessi H. 2018. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications. Int J Pharm. 535(1-2):1–17.
   PubMed Web of Science ®Google Scholar
• Santos GA, Angelo T, Andrade LM, Silva SMM, Magalhães PO, Cunha-Filho M, Gelfuso GM, Taveira SF, Gratieri T. 2018. The role of formulation and follicular pathway in voriconazole cutaneous delivery from liposomes and nanostructured lipid carriers. Colloids Surf B Biointerfaces. 170(June):341–346.
   PubMedGoogle Scholar
• Sarkar R, Narayan V. 2017. Pityriasis versicolor. In: Rigopoulos D, Katoulis A, editors. Hyperpigmentation. 1st ed. FL: p. 52–57.
   Google Scholar
• Schäfer-Korting M, Mehnert W, Korting HC. 2007. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 59(6):427–443.
   PubMed Web of Science ®Google Scholar
• Schechtman RC, Silva NDV, Quaresma MV, Bernardes-Filho F, Buçard AM, Sodré CT. 2015. Dermatoscopic findings as a complementary tool in the differential diagnosis of the etiological agent of tinea capitis. An Bras Dermatol. 90(3 Suppl 1):13–15.
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W, Lucks JS, Müller RH. 1994. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release. 30(1):83–96.
   Web of Science ®Google Scholar
• Shemer A, Babaev M. 2018. Fungal infections (Onychomycosis, Tinea Pedis, Tinea Cruris, Tinea Capitis, Tinea Manuum, Tinea Corporis, different Candida Infections, and Pityriasis Versicolor) and mycological laboratory analyses. In: Tur E, Maibach HI, editors. Gender and dermatology. Cham: Springer International Publishing; p. 235–242.
   Google Scholar
• Singh S, Singh M, Tripathi CB, Arya M, Saraf SA. 2016. Development and evaluation of ultra-small nanostructured lipid carriers: novel topical delivery system for athlete's foot. Drug Deliv Transl Res. 6(1):38–47.
   PubMed Web of Science ®Google Scholar
• Song SH, Lee KM, Kang JB, Lee SG, Kang MJ, Choi YW. 2014. Improved skin delivery of voriconazole with a nanostructured lipid carrier-based hydrogel formulation. Chem Pharm Bull (Tokyo)). 62(8):793–798.
   PubMed Web of Science ®Google Scholar
• Souto EB, Baldim I, Oliveira WP, Rao R, Yadav N, Gama FM, Mahant S. 2020. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opin Drug Deliv. 17(3):357–377.
   PubMed Web of Science ®Google Scholar
• Spósito L, Oda FB, Vieira JH, Carvalho FA, Dos Santos Ramos MA, de Castro RC, Crevelin EJ, Crotti AEM, Santos AG, da Silva PB, et al. 2019. In vitro and in vivo anti-Helicobacter pylori activity of Casearia sylvestris leaf derivatives. J Ethnopharmacol. 233:1–12.
   PubMed Web of Science ®Google Scholar
• Svetlichny G, Külkamp-Guerreiro IC, Cunha SL, Silva FEK, Bueno K, Pohlmann AR, Fuentefria AM, Guterres SS. 2015. Solid lipid nanoparticles containing copaiba oil and allantoin: Development and role of nanoencapsulation on the antifungal activity. Pharmazie. 70(3):155–164.
   PubMed Web of Science ®Google Scholar
• Tiwari S, Mistry P, Patel V. 2014. SLNs based on co-processed lipids for topical delivery of terbinafine hydrochloride. J Pharm Drug Dev. 1(6):1–8.
   Google Scholar
• Vaghasiya H, Kumar A, Sawant K. 2013. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. Eur J Pharm Sci. 49(2):311–322.
   PubMed Web of Science ®Google Scholar
• Vander Straten MR, Hossain MA, Ghannoum MA. 2003. Cutaneous infections dermatophytosis, onychomycosis, and tinea versicolor. Infect Dis Clin North Am. 17(1):87–112.
   PubMed Web of Science ®Google Scholar
• Waśkiel-Burnat A, Rakowska A, Sikora M, Ciechanowicz P, Olszewska M, Rudnicka L. 2020. Trichoscopy of Tinea Capitis: a systematic review. Dermatol Ther (Heidelb)). 10(1):43–52.
   PubMed Web of Science ®Google Scholar
• Weber S, Zimmer A, Pardeike J. 2014. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art. Eur J Pharm Biopharm. 86(1):7–22.
   PubMed Web of Science ®Google Scholar
• Westerberg DP, Voyack MJ. 2013. Onychomycosis: current trends in diagnosis and treatment. 88(11):762–770.
   Google Scholar